Keywords: astrazeneca, begins, revert, trial, initiated, reversal, ventricularremodelling

AstraZeneca begins REVERT trial

Article | 31 August 2001

Print This

AstraZeneca has initiated the REVERT (Reversal of VentricularRemodelling with Toprol XL) clinical trial to evaluate the ability of its beta ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in